Detalles de la búsqueda
1.
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Clin Gastroenterol Hepatol;
21(13): 3365-3378.e5, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36731588
2.
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.
Scand J Gastroenterol;
57(11): 1312-1320, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722732
3.
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics.
Scand J Gastroenterol;
57(5): 566-573, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188859
4.
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
Am J Gastroenterol;
115(11): 1812-1820, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33156100
5.
Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding.
Liver Int;
38(3): 469-476, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164762
6.
Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding.
Hepatology;
61(3): 1024-32, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25179168
7.
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.
Clin Transl Gastroenterol;
14(12): e00607, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523417
8.
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Front Immunol;
14: 1243898, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701431
9.
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
J Crohns Colitis;
17(9): 1418-1425, 2023 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988620
10.
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus.
Dig Liver Dis;
54(3): 309-315, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866011
11.
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Am J Gastroenterol;
106(7): 1255-63, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21468012
12.
A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO.
Clin Res Hepatol Gastroenterol;
45(4): 101693, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852957
13.
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
J Crohns Colitis;
15(5): 766-773, 2021 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246337
14.
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease.
Liver Int;
30(9): 1346-54, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20666992
15.
First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
Ann Pharmacother;
44(12): 1998-2000, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21098750
16.
VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study.
J Crohns Colitis;
14(11): 1512-1523, 2020 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417910
17.
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
Dig Liver Dis;
52(3): 268-273, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732444
18.
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
Aliment Pharmacol Ther;
51(7): 719-727, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32080886
19.
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study.
J Crohns Colitis;
14(7): 896-903, 2020 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31930285
20.
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.
Dig Liver Dis;
52(11): 1323-1330, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962965